On Monday, 24th November, Novo Nordisk published a press release, explaining that the Evoke and Evoke+ trials did not confirm superiority of semaglutide versus placebo in the reduction of progression of Alzheimers disease. Although the researchers did report significant reductions in biomarkers associated with Alzheimers, there was no reduction in disease progression in either trial
Lancet Diabetes Endocrinol (2014) 2(11):88593
Nonetheless, it appears less likely that other receptors modulate the observed effects, as a GLP-1R antagonist (Ex9) blocks the ability of the GLP-1R agonists to exhibit their effects on alcohol drinking (Vallof et al., 2015)
Glutathione INGREDIENT Glutathione is the predominant non-protein thiol and functions as an intracellular redox buffer and antioxidant
Can I receive B12 injections if Im pregnant or breastfeeding
The survey also asked respondents how long they stayed on the drugs